Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

1.

Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.

de Wit M, Kant H, Piersma SR, Pham TV, Mongera S, van Berkel MP, Boven E, Pontén F, Meijer GA, Jimenez CR, Fijneman RJ.

J Proteomics. 2014 Mar 17;99:26-39. doi: 10.1016/j.jprot.2014.01.001. Epub 2014 Jan 10.

PMID:
24418523
[PubMed - in process]
2.

Adherence and patients' experiences with the use of oral anticancer agents.

Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG.

Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22.

PMID:
24266637
[PubMed - indexed for MEDLINE]
3.

Breast cancer classification by proteomic technologies: current state of knowledge.

Lam SW, Jimenez CR, Boven E.

Cancer Treat Rev. 2014 Feb;40(1):129-38. doi: 10.1016/j.ctrv.2013.06.006. Epub 2013 Jul 23. Review.

PMID:
23891266
[PubMed - indexed for MEDLINE]
4.

Proteomics of genetically engineered mouse mammary tumors identifies fatty acid metabolism members as potential predictive markers for cisplatin resistance.

Warmoes M, Jaspers JE, Xu G, Sampadi BK, Pham TV, Knol JC, Piersma SR, Boven E, Jonkers J, Rottenberg S, Jimenez CR.

Mol Cell Proteomics. 2013 May;12(5):1319-34. doi: 10.1074/mcp.M112.024182. Epub 2013 Feb 8.

PMID:
23397111
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study.

Hamaker ME, Seynaeve C, Nortier JW, Wymenga M, Maartense E, Boven E, van Leeuwen-Stok AE, de Rooij SE, van Munster BC, Smorenburg CH.

Breast. 2013 Aug;22(4):556-9. doi: 10.1016/j.breast.2012.12.010. Epub 2013 Jan 8.

PMID:
23305962
[PubMed - indexed for MEDLINE]
6.

The use of capecitabine in daily practice: a study on adherence and patients' experiences.

Timmers L, Swart EL, Boons CC, Mangnus D, van de Ven PM, Peters GJ, Boven E, Hugtenburg JG.

Patient Prefer Adherence. 2012;6:741-8. doi: 10.2147/PPA.S36757. Epub 2012 Oct 19.

PMID:
23118530
[PubMed]
Free PMC Article
7.

Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial.

Duijts SF, van Beurden M, Oldenburg HS, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA, Menke-Pluymers MB, Plaisier PW, Rijna H, Lopes Cardozo AM, Timmers G, van der Meij S, van der Veen H, Bijker N, de Widt-Levert LM, Geenen MM, Heuff G, van Dulken EJ, Boven E, Aaronson NK.

J Clin Oncol. 2012 Nov 20;30(33):4124-33. doi: 10.1200/JCO.2012.41.8525. Epub 2012 Oct 8.

PMID:
23045575
[PubMed - indexed for MEDLINE]
Free Article
8.

Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension.

Eechoute K, van der Veldt AA, Oosting S, Kappers MH, Wessels JA, Gelderblom H, Guchelaar HJ, Reyners AK, van Herpen CM, Haanen JB, Mathijssen RH, Boven E.

Clin Pharmacol Ther. 2012 Oct;92(4):503-10. doi: 10.1038/clpt.2012.136. Epub 2012 Sep 5.

PMID:
22948895
[PubMed - indexed for MEDLINE]
9.

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours.

Kaye S, Aamdal S, Jones R, Freyer G, Pujade-Lauraine E, de Vries EG, Barriuso J, Sandhu S, Tan DS, Hartog V, Kuenen B, Ruijter R, Kristensen GB, Nyakas M, Barrett S, Burke W, Pietersma D, Stuart M, Emeribe U, Boven E.

Br J Cancer. 2012 May 22;106(11):1728-34. doi: 10.1038/bjc.2012.158. Epub 2012 Apr 24.

PMID:
22531637
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation.

Ruiterkamp J, Voogd AC, Tjan-Heijnen VC, Bosscha K, van der Linden YM, Rutgers EJ, Boven E, van der Sangen MJ, Ernst MF; Dutch Breast Cancer Trialists' Group (BOOG).

BMC Surg. 2012 Apr 2;12:5. doi: 10.1186/1471-2482-12-5.

PMID:
22469291
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.

Warmoes M, Jaspers JE, Pham TV, Piersma SR, Oudgenoeg G, Massink MP, Waisfisz Q, Rottenberg S, Boven E, Jonkers J, Jimenez CR.

Mol Cell Proteomics. 2012 Jul;11(7):M111.013334. doi: 10.1074/mcp.M111.013334. Epub 2012 Feb 24.

PMID:
22366898
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.

Vermaat JS, Gerritse FL, van der Veldt AA, Roessingh WM, Niers TM, Oosting SF, Sleijfer S, Roodhart JM, Beijnen JH, Schellens JH, Gietema JA, Boven E, Richel DJ, Haanen JB, Voest EE.

Eur Urol. 2012 Oct;62(4):685-95. doi: 10.1016/j.eururo.2012.01.020. Epub 2012 Jan 23.

PMID:
22285764
[PubMed - indexed for MEDLINE]
13.

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB.

Hum Brain Mapp. 2012 Dec;33(12):2971-83. doi: 10.1002/hbm.21422. Epub 2011 Sep 23.

PMID:
22095746
[PubMed - indexed for MEDLINE]
14.

Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.

van Dijk PR, Ploeg M, Aben KK, Weijerman PC, Karthaus HF, van Berkel JT, Viddeleer AC, Geboers A, van Boven E, Witjes JA, Kiemeney LA.

ISRN Urol. 2011;2011:458930. doi: 10.5402/2011/458930. Epub 2011 Apr 27.

PMID:
22084800
[PubMed]
Free PMC Article
15.

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.

Timmers L, Beckeringh JJ, van Herk-Sukel MP, Boven E, Hugtenburg JG.

Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1036-44. doi: 10.1002/pds.2225. Epub 2011 Sep 29.

PMID:
21956857
[PubMed - indexed for MEDLINE]
16.

Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer.

van der Veldt AA, Vroling L, de Haas RR, Koolwijk P, van den Eertwegh AJ, Haanen JB, van Hinsbergh VW, Broxterman HJ, Boven E.

Int J Cancer. 2012 Aug 15;131(4):E484-93. doi: 10.1002/ijc.26456. Epub 2011 Nov 8.

PMID:
21953673
[PubMed - indexed for MEDLINE]
17.

Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent.

Ploeg M, Kums AC, Aben KK, van Lin EN, Smits G, Vergunst H, Viddeleer AC, Geboers AD, van Berkel H, van Boven E, Kiemeney LA, Witjes F.

Clin Genitourin Cancer. 2011 Sep;9(1):14-21. doi: 10.1016/j.clgc.2011.05.004. Epub 2011 Jul 1.

PMID:
21723794
[PubMed - indexed for MEDLINE]
18.

The use of erlotinib in daily practice: a study on adherence and patients' experiences.

Timmers L, Boons CC, Mangnus D, Moes JE, Swart EL, Boven E, Smit EF, Hugtenburg JG.

BMC Cancer. 2011 Jul 1;11:284. doi: 10.1186/1471-2407-11-284.

PMID:
21722354
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.

van Leeuwen RW, Swart EL, Boven E, Boom FA, Schuitenmaker MG, Hugtenburg JG.

Ann Oncol. 2011 Oct;22(10):2334-41. doi: 10.1093/annonc/mdq761. Epub 2011 Feb 22.

PMID:
21343376
[PubMed - indexed for MEDLINE]
Free Article
20.

Targeted therapy for renal cell cancer: current perspectives.

van der Veldt AA, Haanen JB, van den Eertwegh AJ, Boven E.

Discov Med. 2010 Nov;10(54):394-405. Review.

PMID:
21122471
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk